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We have previously described gene expression changes during spontaneous immortalization of T-cells, thereby
identifying cellular processes important for cell growth crisis escape and unlimited proliferation. Here, we analyze the
samemodel to investigate the role of genome-widemethylation in the immortalization process at different time points
pre-crisis and post-crisis using high-resolution arrays. We show that over time in culture there is an overall
accumulation of methylation alterations, with preferential increased methylation close to transcription start sites
(TSSs), islands, and shore regions. Methylation and gene expression alterations did not correlate for the majority of
genes, but for the fraction that correlated, gain of methylation close to TSS was associated with decreased gene
expression. Interestingly, the pattern of CpG sitemethylation observed in immortal T-cell cultureswas similar to clinical
T-cell acute lymphoblastic leukemia (T-ALL) samples classified as CpG island methylator phenotype positive. These
sites were highly overrepresented by polycomb target genes and involved in developmental, cell adhesion, and cell
signaling processes. The presence of non-random methylation events in in vitro immortalized T-cell cultures and
diagnostic T-ALL samples indicates altered methylation of CpG sites with a possible role in malignant hematopoiesis.
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Cellular immortalization is a multistep process and a major step in
cancer development. Senescence checkpoint bypass and acquisition ofindefinite replicative capacity in cell cultures have been associated
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pathways [1]. Published data on cellular processes involved in
immortalization have essentially been generated from fibroblasts and
endothelial and epithelial cells, whereas less is known for lymphoid cells
[1–4]. A common feature of immortalized cells is activation of telomerase
through up-regulation of human Telomerase Reverse Transcriptase
(hTERT), the expression of which is regulated by a multitude of factors
includingmodifiers of the chromatin structure [5–7].We have previously
shown that impaired DNA damage response and deregulated cell
senescence control together with activation of telomerase were coupled
to T-cell immortalization [8]. In vitro immortalization of mammary
epithelial cells has been associated with stepwise DNA methylation
alterations [3], and in the present study, we have analyzed methylation
alterations during this process in primary T-cell cultures and in relation
to diagnostic T-cell acute lymphoblastic leukemia (T-ALL) samples.
Epigenetic processes involve DNA methylation and histone modifi-
cations, which can participate in gene regulation without altering the
DNA sequence. DNA methylation frequently occurs on a cytosine
followed by a guanine (CpG sites) [9]. Many CpG-enriched regions
(CpG islands) are located in promoters and methylation of such CpG
islands represents one major transcriptional control mechanism [4].
Abnormal DNA methylation is a hallmark of cancer development and
might lead to silencing of tumor suppressor genes and/or activation of
oncogenes [9–11]. Specific CpG islands are commonly methylated in
malignancies and themethylation pattern seems to be tumor type specific
[3,9,11–15]. Epigenetic repression of the INK4a/ARF locus, encoding
the tumor suppressors p16INK4a and p14ARF, is a frequent event during
immortalization of fibroblasts and epithelial cells [2,16,17]. In addition,
hypomethylation of intragenic regions may result in derepression of
transposable elements contributing to genomic instability [9].
Analysis of the impact of DNA methylation on processes relevant
for cellular immortalization in vitro is complicated due to the fact that
successive methylation changes may occur by time and number of
population doublings (PDs). Long-term culture of fibroblasts and
mesenchymal stromal cells is associated with specific senescence-
associated DNA methylation changes [18]. In mesenchymal stromal
cells, overexpression of TERT or immortalization with a doxycycline-
inducible system (TERT and SV40-TAg) resulted in telomere extension
but did not prevent senescence-associatedDNAmethylation [19]. It was
also noted that methylation patterns were maintained throughout both
long-term culture and aging but with highly significant differences
at specific CpG sites [20]. However, for hematopoietic cells in vitro
data are conflicting and limited to Epstein Barr Virus (EBV)-
transformed lymphoblastoid B cell lines [21,22].
In the present study, genome-wide promoter-associatedmethylationwas
analyzed during spontaneous immortalization of T-cell cultures established
from patients with Nijmegen breakage syndrome (NBS) and a healthy
individual, using high-density arrays. A significant number of CpG site
alterations throughout immortalization were shared with pediatric T-ALL
suggesting a clinical relevance of these methylation changes.
Materials and Methods
T-cell Cultures and Culture Conditions
The studied T-cell cultures were established at the Sklodowska-Curie
Memorial Cancer Center in Warsaw, Poland, and at Umeå University
in Umeå, Sweden, using mitogen-initiated, Interleukin-2 (IL-2)–
dependent cultures without genetic manipulations, as previously
described [8,23,24]. The spontaneously immortalized T-cell lines(S3R, S4, and S9) were established from peripheral blood mononuclear
cells derived from patients with NBS homozygous for the 657del5
mutation of the NBS1 gene [8,23]. T-cell lines (L4 and L5) and their
parental population (L2) as well as the primary T lymphoblast culture S1/
PHAwere derived from normal spleen [24]. The primary T-lymphoblast
culture P7/R2 was derived from peripheral blood mononuclear cells of a
healthy donor and was generated after initial 24-hour activation with
20 μg/ml Wheat Germ Agglutinin (WGA), followed by culture in
standard medium without mitogen for the next 5 days and thereafter
propagation in 20U/ml of rIL-2 for 14 PDs. All cultures weremaintained
in standard medium [RPMI 1640, 10-12% fetal calf serum, 50 μg/ml
gentamicin (Sigma-Aldrich, St Louis,MO)] supplemented with 20U/ml
rIL-2 (R&D Systems, Minneapolis, MN), in 5% CO2 at 37°C. An
approval from the Ethical Council in Warsaw, Poland, was obtained
before collection of the NBS blood samples and the patients’ guardians
provided informed consent.
Cell cultures were grouped accordingly: primary with limited life-span
in vitro (P7/R2 14 PDs, S1/PHA 2 PDs), pre-immortal (S3R 17 PDs, S4
12/18/48 PDs, S9 10 PDs, L2 5 PDs), and immortal (S3R 27/76/192
PDs, S4 68/223 PDs, S9 104 PDs, L4 195 PDs, L5 157 PDs). Pre-
immortal and immortal T-cell cultures were separated by a period of
growth crisis, in S3R at 21 to 25 PDs and in S4 at 62 to 67 PDs, but with
no clear growth crisis period in cultures S9, L4, or L5.
T-ALL Samples
Diagnostic bone marrow samples from 43 pediatric T-ALL patients
collected at the University Hospital in Umeå, Sweden, have been
previously analyzed by the HumMeth27K (n = 43) andHumMeth450K
(n = 10) Illumina methylation arrays (Illumina, San Diego, CA) and
classified regarding CpG island methylator phenotype (CIMP) status
[25]. Methylation array data from the HumMeth27K array was
downloaded from the National Center for Biotechnology Information
(NCBI) Gene Expression Omnibus (GEO) database, GSE42079, and
data from the HumMeth450K array has been deposited to the GEO
database, GSE56070. The Regional Ethics Committee approved the
study, and the patients and/or their guardians provided informed consent.
DNA Preparation
DNA was prepared with the Nucleon BACC2 kit (Amersham
Biosciensces AB, Uppsala, Sweden) and DNA purity and concentration
were determined by spectrophotometry (NanoDrop; Thermo Scientific,
Wilmington, DE).
Genome-Wide CpG Site Methylation Profiling
The cell cultures were analyzed at different stages during
immortalization using a high-density array covering 485,577 CpG
sites (HumMeth450K, Illumina). The included CpG sites are located
in different genomic regions, but the main focus is promoter-
associated regions and CpG islands. The array definition of genomic
regions and the relations to CpG islands are shown in Supplementary
Figure S1. A methylated control sample (Human HCT116 DKO
methylated DNA; Zymo Research, Irvine, CA, USA) enzymatically
methylated on all cytosines by M.SssI methyltransferase and a non-
methylated (b5%) control double knocked out for DNA methyltrans-
ferases (DNMT1−/− and DNMT3B−/−; HumanHCT116DKO non-
methylated DNA; Zymo Research) were included. For each sample,
500 ng of DNA was bisulfite converted with the EZ-96 DNA
Methylation-Gold Kit (Zymo Research) according to the manufacturer’s
manual. Two hundred nanograms of bisulfite-converted DNA was
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provided protocol and scanned with an iScan SQ instrument (Illumina).
The fluorescence intensities were extracted using theMethylationmodule
(1.9.0) in the Genome Studio software (V2011.1).
Pre-Processing of Methylation Array Data
CpGs on the X and Y chromosomes were omitted from the analysis to
avoid gender-related methylation biases. In addition, CpG sites lacking
observations due to less than or equal three reported beads/array or CpG
sites with low detection P value (N .05) were excluded. Likewise, CpG
sites located at or close to a (10-bp) single nucleotide polymorphism
(SNP) as well as CpG sites located in intergenic regions were excluded. All
filtration steps are shown in Supplementary Figure S2. The methylation
levels for the remaining 330,354 CpG sites were determined by
calculating the ratio (i.e., the β value) between the fluorescent intensity
from the methylated alleles and the total intensity, as defined in the
Genome Studio software (Illumina). The β value ranges in theory from 0,
corresponding to completely unmethylatedDNA, to 1, representing fully
methylatedDNA.To compensate for the two different bead types used in
theHumMeth450K array, theβ values were normalized using the BMIQ
method [26,27].
The methylation array data have been deposited to the NCBI GEO
database, GSE56070.
Verification of Methylation Array Data by Pyrosequencing
DNA samples were sent to the Genome Centre Queen Mary,
University of London for targeted pyrosequencing on a selection of
genomic regions overlapping with specific CpGs in the methylation array,
including TAL1 (cg19797376), KLF4 (cg07309102), HOXD8
(cg15520279), and TWIST1 (cg24446548). Pyrosequencing was
performed according to the manufacturer’s protocol by bisulfite treatment
ofDNA (EZDNAMethylation; ZymoResearch), followed by polymerase
chain reaction (PCR) amplification and pyrosequencing using PyroMark
Gold Q96 Reagents (Qiagen, Sollentuna, Sweden) in the PSQ 96MA
instrument with PSQ 96MA software V2.1 (Qiagen). The following set of
primers were used: TAL1_F: ATGGGGGTTAGAGAGAGAATGA;
TAL1_R:ACCTCCTCAACCAAATCTC; TAL1_seq: GGGGGATTT
TAAGGT; HOXD8_F: AGTGATAGTAGTAGTAAGTGGGATT
GAT; HOXD8_R: AACAACCCCCCCACAAACCCC; HOXD8_seq:
GTTTTGTATTTGGAGTATAG; KLF4_F: AGGTTGTAGAGAAG
GAAGTTATAAGTAAG; KLF4_R: CAACAACCTCCCCCACCAC
TAT; KLF4_seq: ATACCCCCAAATAAAACTAACTAC; TWIST1_F:
GGAGGTATAAGAGTTTTTAAGTTTGTAG; TWIST1_R:
ACACCCCCCCAAACCTCCTA; TWIST1_seq: AGAGTTTT
TAAGTTTGTAGTT.
RNA Preparation and Pre-Processing of Gene
Expression Data
Total RNA was isolated using TRIzol reagent (Invitrogen,
Stockholm, Sweden) according to the manufacturer’s protocol.
The RNA quality was analyzed in a 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA) and RNA integrity number was N9 in
all samples. In brief, 200 ng of total RNA was used for cRNA
production by the Illumina TotalPrep RNA amplification kit (Ambion
Inc, St Austin, TX) according to the provided protocol. The biotin-
labeled cRNAwas purified and the quality was evaluated using the RNA
6000 pico kit in the 2100 Bioanalyzer (Agilent Technologies).
A total of 750 ng of biotinylated cRNA was hybridized to the
human HT12 Illumina Beadchip gene expression array (Illumina)according to the manufacturer’s protocol and scanned using the
Illumina Bead Array Reader (Illumina). Illumina Genome Studio
software (V2011.1) with gene expression module (1.9.0) was used
for data extraction and normalization using the rank invariant
normalization. Selected parts of the gene expression array data have
been previously published [8]. Gene expression array data have been
deposited to the NCBI GEO database, GSE56070.
Quantitative Reverse Transcription–PCR Analysis
cDNA was prepared by reverse transcription (RT) of 500 ng
of total RNA with the Superscript II Reverse Transcriptase kit
(Invitrogen) together with random hexamers (Applied Biosystems, Inc,
Foster City, CA) andRNasin (Promega,Nacka, Sweden) according to the
manufacturer’s instructions (Invitrogen).
Expression levels of selected genes were determined by quantitative
PCR in duplicates and a standard curve was included in each assay to
monitor PCR efficiency. The following genes were analyzed byTaqMan
assays on demand according to the manufacturer’s protocol using the
TaqMan Universal PCR Mastermix in the ABI PRISM 7900HT
Instrument (Applied Biosystems, Inc): TATA-binding protein gene
(TBP) (Hs99999910_m1), BMI1 polycomb ringfinger oncogene (BMI1)
(Hs00180411_m1) , Chr omobo x h omo l o g 2 (CBX2 )
(Hs01034268_m1), chromobox homolog 7 (CBX7) (Hs00545603_s1),
Enhancer of Zeste homolog 2 (EZH2) (Hs01016789_m1), and supressor
of Zeste 12 (SUZ12) (Hs00248742_m1). Relative mRNA levels were
normalized to a housekeeping TBP gene and fold change was calculated
by the 2−ΔΔCt method using P7/R2 and S1/PHA as primary mortal
T-cell culture references [28].
Bioinformatic and Statistical Analyses
Downstream analyses of the methylation and gene expression array
data were performed using R (v2.15.0). The CpG sites were matched
to genes on the expression array according to their RefSeq accessions.
Gene annotations from both gene expression and methylation arrays
were matched to the hg19 assembly (NCBI) and their annotations
were updated. Genes with discontinued accessions or non-consistent
annotations were excluded from further analysis. In the downstream
analysis, the normalized β values and the log2-transformed normalized
signal intensities were used as measures of methylation and gene
expression levels, respectively.
The primary T-lymphoblast culture P7/R2 was used as a universal
reference and the methylation pattern for each time point of the two cell
cultures was analyzed in relation to P7/R2 (Figure 1). The CpG sites were
classified as de novo altered CpGs if the difference in β values was greater
than 0.4 (gain of methylation) or less than −0.4 (loss of methylation).
Although the methylation of the P7/R2 cell line was highly correlated with
the pre-crisis samples in each cell line, it was excluded from further analysis
of differential methylation and expression in the S3R and S4 cell cultures.
For each CpG site, the alteration between post-crisis and pre-crisis
samples was measured with the maximum differences in methylation
(δβ). CpG sites with an δβ greater than 0.4 or less than −0.4 were
classified as differentially methylated (DM-CpG). For gene expres-
sion, genes expressed at background level were censored to the largest
of the 95th percentiles of the negative controls across the arrays. The
alteration between post-crisis and pre-crisis samples was then
measured with the maximum differences in log2-transformed
censored intensities (M). Genes with an M value greater than log2
(1.7) or less than − log2(1.7), corresponding to a fold change of 1.7
and expressed above background level were classified as differentially
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Figure 1.Methylation alterations accumulated during the immortalization process. The number of de novo altered CpG sites at increasing
PDs (A and B) or days in culture (C and D) in S3R (A and C) and S4 (B and D) is shown. The gain of methylation is defined as δβ N0.4, and
loss of methylation is defined as δβ b −0.4, compared with a stimulated primary T-cell culture (P7/R2). The growth crisis periods are
marked with asterisks.
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Supplementary Figure S2. Differently methylated gene (DMG) and
DEG found in both cell cultures (DMG/DEG) were selected for
further analysis (Figure 2). The significance of the overlaps between
the two cell cultures was determined using the chi-square test.
The significance of the overlap between DMG and DEG (Figure 2)
and distributions of downregulated genes among methylated and
demethylated genes (Table 2) were evaluated using a permutation-based
test. While keeping the gene-CpG structure intact, the gene expression
profiles were randomly assigned to genes 2000 times. Thus, the
distributions under the null hypothesis of independence between
methylation and gene expression and P values for the size of the overlap
and the distribution of downregulated genes were obtained.
To analyze common methylation patterns between the two T-cell
cultures and T-ALL samples, hierarchical clustering with Euclidean
distance matrix using the Ward method [29] was performed and
visualized in a heat map. Publicly available sorted T-cells (CD3+) and
hematopoietic stem cells (CD34+CD38−) from healthy donors were
used as controls. The methylation data from the sorted cells were
previously published by the Cancer Genome Atlas Research Network
[30] and were downloaded from theNCBIGEO database, GSE49618.
The polycomb target gene (PCTG) lists from Lee et al. [31] were
compared with the genes with common methylation changes between
T-ALL samples and T-cell cultures. We hypothesized that the
proportion of PCTGs in the list of shared changed CpG sites was
larger than expected by chance and we tested our hypothesis using a
binominal test. The systems biology tool Metacore from GeneGo Inc(St Joseph, MI) was used to identify networks and processes of
possible relevance for immortalization.Results
Quality Control and Reproducibility of Methylation
Array Data
The quality of each individual array was evaluated with the built-in
controls, i.e., bisulfite conversion, staining, negative controls, hybrid-
ization, and specificity. A replicate sample was included in the
HumMeth450K array to assess inter-assay reproducibility (R2 =
0.989). Selected genomic regions for TAL1 (cg19797376), KLF4
(cg07309102), TWIST1 (cg24446548), and HOXD8 (cg15520279)
were separately analyzed by pyrosequencing at increasing PDs in the
S3R and S4 cell cultures and compared with CpG site data from the
HumMeth450K array, showing a strong correlation between the
methods (Supplementary Figure S3).DNA Methylation Alterations during T-Cell Immortalization
Genome-wide promoter methylation status was determined by the
HumMeth450K array at different stages during spontaneous
immortalization of the two human T-cell cultures, S3R and S4.
Both cultures experienced a growth crisis period, between 21 and 25
PDs (93 days) in S3R and between 62 and 67 PDs (45 days) in S4.
After pre-processing of the array data, as detailed in the Materials and
Methods section and in Supplementary Figure S2, 330,354 CpG sites
DM-CpG
S3R S3R
S4 S4
DEG
noisserpxEeneGnoitalyhteM
27317 CpG
33885 CpG
2367 genes
1275 genes
17465 CpG
(6596genes)
1790 genes
DMG/DEG
624 genes¤* *
Figure 2. Commonly DM-CpG sites and differentially expressed genes in immortal T-cell cultures. (A) The DM-CpG sites (δβ N 0.4 or b−0.4)
and theDMG (fold change±1.7) pre-crisis versuspost-crisis in theS3R andS4 cell cultureswere combined in Venndiagrams. The commonly
DM-CpG sites (17,465 CpGs representing 6596 genes) andDEG (1790 genes) are highlighted in the figure aswell as the combinedDMG/DEG
list (624 genes). There was a significantly higher proportion of common DM-CpG and DEG than expected by random (*P b .001) in the
immortal cultures. In contrast, the number of genes that were both DMG and DEG was significantly smaller than expected (¤P b .001).
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analyzed at increasing PDs and compared with a primary stimulated
T-cell culture (P7/R2). Both the S3R and S4 cultures showed an
accumulation of de novo altered CpG sites with increasing PDs
(Figure 1, A and B). The most pronounced change was observed in
cultures escaping from the growth crisis period (S3R 27 PDs and S4
68 PDs; Figure 1, A and B). However, the growth crisis period lasted
for a long period of time and when analyzing methylation changes in
relation to days in culture the rate of changes appeared rather constant
(Figure 1, C and D). The fraction of de novo methylated sites was, in
S3R, 0.3% at 17 PDs (pre-crisis) and 5% at 192 PDs (post-crisis)
and, in S4, 0.1% at 12 PDs (pre-crisis) and 13% at 223 PDs (post-
crisis) of all CpG sites analyzed and in relation to the primary
stimulated T-cell culture (P7/R2). Loss of methylation was lessTable 1. Preferential Methylation in CpG Islands and Regions around TSS
Average methylation (average β) of the commonly differently methylated 17,465 CpG sites for the re
a scale from unmethylated (green) to fully methylated (red) as shown in the figure.common in S4 in comparison to the S3R culture, in which gain and
loss of methylation were equally common (Figure 1, A–D).
Next, by filtering for shared DM-CpG sites (demethylated or
methylated) between the cultures pre-crisis versus post-crisis, a
significantly larger overlap (P b .001) than expected by random
was observed. This overlap consisted of 17,465 DM-CpGs with
potential importance for immortalization (Figure 2). By focusing on
these DM-CpGs, it was further shown that the unmethylated CpG
sites close to transcription start sites (TSSs) (TSS200/exon 1) and
CpG islands (islands/shores) were preferentially and gradually
methylated during the process (Table 1 and Supplementary Figure
S4). Demethylation was observed in methylated regions far away from
CpG islands, here titled “open sea” and “shelf” (Table 1 and
Supplementary Figure S4).spective genomic region and CpG island location is shown at increasing PDs. The colors represent
Table 2. Decreased Gene Expression Was Associated with Increased Methylation around TSS and
Decreased Methylation in Gene Body
Genomic Region Methylated Demethylated
TSS1500 61* 52
TSS200 70*** 50
5′UTR 68*** 53
First exon 60 0***1
Body 58 69***
3′UTR 64 79***
The percentage of downregulated genes in gene regions that were methylated/demethylated
is shown. For the significance based on permutation of gene expression probes, expected percentage
of downregulated genes is 50% to 51% in all categories. The level of significance is represented by
*P b .05, **P b .01, and ***P b .001; 1 denotes categories with less than five observations.
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Differently Expressed Genes
In addition to the DM-CpGs, a significant overlap (P b .001) of
1790 differently expressed genes (DEG) either upregulated or
downregulated pre-crisis versus post-crisis was identified, indicating
shared pathways for immortalization (Figure 2). A gene with at least
one DM-CpG was defined as a DMG. The DMG and the DEG lists
were combined and an overlap of 624 genes both differentially
methylated and differentially expressed was identified (DMG/DEG).
The DMG/DEG list was analyzed for associations to methylation
in different genomic regions. A significant overrepresentation of
downregulated genes was observed when methylation occurred close
to TSS (P b .001; Table 2). In contrast, decreased methylation
within the gene body region was associated with decreased expression
(P b .001; Table 2). However, the DMG/DEG overlap was
significantly lower than expected by random (P b .001), indicating
that the majority of methylation alterations have little or no effect on
gene expression levels (Figure 2).
Functional Analysis of Shared DM-CpGs in
Immortal T-Cell Cultures and T-Cell Leukemia
To identify methylation alterations of potential importance for
both in vitro T-cell immortalization and in vivo malignancy, we
applied data from 10 diagnostic pediatric T-ALL samples (7 CIMP+
and 3 CIMP−) on a heat map showing the 17,465 commonly
altered CpGs in the immortal S3R and S4 T-cell cultures
(Figures 2 and 3A). Sorted cells from healthy donors were used
as controls [30]. CD34+/CD38− hematopoietic stem cells represented
immature T-cells andCD3+ representedmature T-cells. Immature and
mature T-cells showed similar methylation profiles as pre-immortal cell
cultures regarding the CpG sites that were commonly altered during the
immortalization process (Figure 3A).
Hierarchical clustering of the cell cultures and leukemias separated
the CpGs into three clusters; cluster 1 in which de novo methylated
CpGs in the immortal cells overlapped with methylated CpGs in
CIMP+ T-ALL diagnostic samples. CpGs in cluster 2 were de novo
methylated in immortal cell cultures but less methylated in leukemia,
and cluster 3 demethylated in immortal cell cultures but methylated
in leukemia (Figure 3A). Bioinformatic analysis revealed a significant
overrepresentation (P b .001) of PCTGs [31] compared to random
methylation (Figure 3A) in all clusters, but the overrepresentation was
most evident in cluster 1 where 51% of the CpG sites were located in
PCTGs compared to 23% and 21%, respectively, in clusters 2 and 3.
Furthermore, the majority (62%) of the shared CpG sites in immortal
cell cultures and CIMP+ leukemias were located in CpG islands.To verify the overlap in altered genes in immortal T-cell cultures
and CIMP+ T-ALL, data from 43 diagnostic T-ALL samples
analyzed on the HumMeth27K array as well as three additional cell
cultures derived from one patient with NBS and one healthy
individual were included; 1478 CpG sites of the 17,465 shared DM-
CpGs (Figure 2) were present in the HumMeth27K array. Cell
cultures and leukemias were clustered, and CpGs sorted in the three
clusters were identified in Figure 3A. All immortal cell cultures
showed similar alterations and cluster 1 was commonly methylated in
immortal cell cultures and CIMP+ leukemias (Figure 3B).
To further investigate the cellular pathways commonly altered in
immortal cell cultures and leukemia, the list of shared DM-CpGs in
cluster 1 (Figure 3A) was applied to Metacore process network
analysis (Figure 4, A–C). The resulting P values were compared at
increasing PDs in cell cultures, in grouped CIMP+ (n = 7) and
CIMP− (n = 3) leukemias, and the list of PCTGs [31] (Figure 4, A
and B). This comparison allowed assessment of the number of
alterations for each individual process network with corrections for
pathway and gene list sizes. The process networks of highest relevance
were cell adhesion, cytoskeletal remodeling, development, and signal
transduction processes (Figure 4B). Interestingly, a large set of genes in
theWnt signaling pathway became methylated during immortalization
of cell cultures and in diagnostic CIMP-positive leukemias (Figure 4C).
To identify potentially deregulated components/pathways in the
methylation and chromatin modifying machinery during immortal-
ization, we analyzed gene expression of DNA methyltransferases
(DNMT1, DNMT3A, and DNMT3B) and polycomb repressive
complex 1 (PRC1) and PRC2 genes in the S3R and S4 cell cultures.
PRC1/2 was significantly changed regarding the EZH2 (S3R, S4),
BMI1 (S4), PCGF2 (S3R, S4), CBX2 (S3R, S4), and CBX6 (S3R,
S4) genes, all showing up-regulation. In contrast, decreased levels of
CBX4 (S3R) and CBX7 (S3R, S4) were recorded. In S3R, DNMT1
remained stable throughout the culture, whereas DNMT3A and
DNMT3B decreased (Supplementary Figure S5). In contrast, S4
showed increased expression of DNMT1 and stable expression of
DNMT3A and 3B (Supplementary Figure S5).
Discussion
Here, we have shown that spontaneous immortalization of T-cell
cultures was associated with common DNA methylation alterations
found to be shared at a high frequency with CIMP+ T-ALL
diagnostic samples, indicating that the in vitro established methyl-
ation alterations might be relevant in the clinical setting.
In our study, two IL-2–dependent T-cell cultures were analyzed
with a high-density genome-wide methylation array at several time
points, from primary culture, over a growth crisis period, and until
clonal immortal cell cultures emerged (approximately 350-400 days).
We have previously shown that the initial polyclonal cultures
gradually became monoclonal indicating a continuous loss of cells
likely due to the senescence program [8,23]. Methylation changes
were recorded in pre-immortal S4 cells already before the growth
crisis period, which might have contributed to senescence bypass/
growth crisis escape. The accumulation of methylation alterations was
rather constant when analyzing changes against days in culture. In
contrast, when analyzed in relation to PDs, the changes appeared
more stepwise. Stepwise methylation changes have been recorded
during immortalization of human mammary epithelial cell cultures in
which a “stasis” (stress-induced senescence barrier) and a “telomere
dysfunction” (i.e., crisis) barrier were identified [3,32]. The
Cluster 1
CGI: 62%
OS: 10%
PCTGs: 51%
Cluster 3
CGI: 2%
OS: 70%
PCTGs: 21%
Cluster 2
CGI: 51%
OS: 18%
PCTGs: 23%
CD34+/CD38- Hematopoietic stem cells
CD3+ Mature T-cells
Pre-immortal cell cultures
Immortal cell cultures
CIMP- T-ALL
CIMP+ T-ALL
Pre-immortal cell cultures
Immortal cell cultures
CIMP- T-ALL
CIMP+ T-ALL
Cluster 1
Cluster 3
Cluster 2
A B
Figure 3. Shared methylation alterations in immortal T-cell cultures and diagnostic CIMP+ T-ALL samples. (A) Methylation
HumMeth450K array data for the commonly altered 17,465 CpGs in T-cell cultures visualized in a heat map together with 10 diagnostic
T-ALL samples. Separated CD34+/CD38− (hematopoietic stem cells, n= 3) and CD3+ (mature T-cells, n= 3) cells from healthy donors
were included as controls. The CpG sites were separated into three distinct clusters. The percentage of CpG sites located within
CpG islands (CGI) and open sea (OS) regions in each cluster is displayed as well as the percentage of PCTGs in each cluster defined by
Lee et al. [31]. The diagnostic T-ALL sample CIMP status is shown in the figure as well as the pre-immortal or post-immortal status of the
cell cultures. (B) Verification of shared altered CpG sites in immortal cell cultures and in CIMP+ T-ALL leukemias by HumMeth27K array
analysis; 1478 CpGs of the 17,465 CpGs commonly altered CpG sites in immortal S3R and S4 cultures were present in the 27K array and
used to verify data in a larger number of T-ALL samples and in three additional cell cultures derived from one patient with NBS (S9) and
one healthy individual (L4 and L5).
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achieved and thereby not comparable to the spontaneously
immortalized T-cells analyzed in the present study.
Both T-cell cultures studied showed an accumulation of de novo
altered CpG sites during immortalization, with similar levels of gain
and loss of methylation for S3R while culture S4 was dominated by
gain of methylated CpG sites. Interestingly, the two cultures shared a
large fraction of DM-CpG sites between pre-crisis and post-crisis
cells. For these sites, a preferential gain of methylation in CpG islands
and CpG sites located close to TSS was observed, whereas loss of
methylation preferentially occurred in gene body regions and at sites
located far away from CpG islands (“open sea”). Genomic regions
close to TSS are known to contain a high density of CpG islands,
whereas the gene body has a lower density, explaining the overlapping
results of genomic regions and CpG island relations [9]. The
chromosomal distribution of the methylation alterations paralleledthe distribution of CpG sites on the array, and methylation alterations
therefore appeared as a genome-wide phenomenon (data not shown).
The collected findings of common and non-random methylation
changes in the immortalized T-cells indicate a functional meaning.
One question was to what extent the methylation pattern was coupled
to gene expression. To answer this question, we combined methylation
data with our previously published gene expression array data [8].
Methylation and gene expression did not correlate for the majority of
genes, indicating that many methylation alterations did not relate to
gene expression. However, we could identify genes with strong negative
or positive correlation to methylation status. The direction of the
correlation seemed to depend on where in the promoter region the
methylation occurred. Generally, silenced gene expression was
significantly associated with increased methylation close to TSS and
loss of methylation in the gene body region. However, increased
methylation within the gene bodywas observed as well andmight reflect
Figure 4. Ontology analysis of common cellular processes affected by methylation. Metacore process network analysis of the shared 8255
CpG sites (cluster 1; Figure 3A) between post-crisis T-cell cultures and diagnostic CIMP+T-ALL (A). CIMP− (n=3) and CIMP+ (n=7) T-ALL
samplesweregrouped in the analysis,whereas each timepoint is shown for the cell cultures. A significant process (P b .05) is indicated in red
in the heat map. (B and C) The top processes in the Metacore process network analysis are shown as well as the WNT signaling genes
representing aprocesswithmany affectedgenes. The red thermometers represents (1) polycomb target genes and (2) shared8255CpGsites
in post-crisis T-cell cultures/CIMP+ T-ALL.
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Varley et al. [33].
To identify methylation alterations of potential importance for
both in vitro T-cell immortalization and in vivo malignancy, weapplied data from diagnostic pediatric T-ALL samples to the analysis.
T-ALL originates from precursor cells in the bone marrow, whereas
our T-cell culture models are derived from mature peripheral blood
lymphocytes. However, the methylation profiles of the CpG sites that
614 DNA methylation and T-cell immortalization Degerman et al. Neoplasia Vol. 16, No. 7, 2014were differently methylated during the immortalization process were
comparable between immature and mature cells from healthy donors
and pre-immortal cell cultures and confirm our T-cell culture model
as suitable for comparable analysis with T-ALL.
We have recently identified methylation alterations within T-ALL
samples separating them into subgroups (CIMP+/CIMP−) with
different prognosis [25]. Interestingly, a substantial fraction of the
altered CpG sites observed in the T-cell cultures had similar
methylation profiles in the CIMP+ T-ALL samples. This common-
ality indicates that the in vitro established methylation changes were
relevant also in the clinical setting. The affected CpG sites were not
unbiased regarding the function of associated genes since differential
methylation of PCTGs was overrepresented. Furthermore, bioinfor-
matic analyses showed a pattern of overlapping networks among the
affected genes in post-crisis T-cell cultures, CIMP+ leukemias, and
the PCTG list [31]. These shared processes were involved in cell
adhesion, cytoskeleton remodeling, development, and signal trans-
duction. Of special notice was a high number of methylation altered
genes in the Wnt signaling pathways. The reason for this is unclear
but indicates selectivity in the methylation targets.
Gene expression alterations of DNA methyltransferases (DNMT1,
DNMT3A, and DNMT3B) as well as subunits in the PRC1/2 were
observed in both cultures suggesting a functional role for the observed
methylation changes during the immortalization process. Previous
observations have shown that different DNAmethylation changes typical
for cancer cellsmay evolve from senescence-related alterations triggered by
different stimuli [34] and alteredDNAmethylation acquired in senescent
cells can be retained when these cells bypass senescence [35].
The three spontaneously immortalized cell cultures, S3R, S4, and S9,
were derived from individuals diagnosed with NBS with increased risk
of leukemia due to DNA repair deficiency. However, the patients were
not diagnosed with any malignancy at the time when the cultures were
established. The observed methylation alterations in the immortal
NBS-derived T-cell cultures overlapped with T-cell cultures derived
from a healthy individual (L4 and L5) indicating general accumulated
methylation alterations during the immortalization process.
In conclusion, our analysis identified a high number of commonly
methylated CpG sites in immortalized T-cell cultures and diagnostic
CIMP+ T-ALL samples with potential significance for malignant
transformation. Whether CIMP+ and CIMP− leukemias represent
subtypes with different routes for transformation has to be further
investigated. One alterative hypothesis is that CIMP+ and CIMP−
leukemias reflect cells with diverse replicative histories, where CIMP+
leukemias might have undergone a large number of replication rounds
and thereby demonstrate DNA methylation pattern similar to long-
term cultured T-cells. These issues have to be further evaluated to
better understand the relevance of methylation during immortaliza-
tion and the development of hematological malignancies.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neo.2014.07.001.
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